These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 25979365)

  • 41. Bias in treatment trials.
    Davies HT
    Hosp Med; 1999 Aug; 60(8):599-601. PubMed ID: 10621819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statistics notes: Concealing treatment allocation in randomised trials.
    Altman DG; Schulz KF
    BMJ; 2001 Aug; 323(7310):446-7. PubMed ID: 11520850
    [No Abstract]   [Full Text] [Related]  

  • 43. The value of control conditions for evaluating pharmacogenetic effects.
    Chen LS; Baker TB; Bierut LJ
    Pharmacogenomics; 2015 Dec; 16(18):2005-6. PubMed ID: 26607722
    [No Abstract]   [Full Text] [Related]  

  • 44. Blinding of clinical trials with concurrent economic analysis.
    Johnson K
    JAMA; 1997 Jun; 277(21):1677. PubMed ID: 9169884
    [No Abstract]   [Full Text] [Related]  

  • 45. Understanding controlled trials. Randomisation methods: concealment.
    Torgerson DJ; Roberts C
    BMJ; 1999 Aug; 319(7206):375-6. PubMed ID: 10435967
    [No Abstract]   [Full Text] [Related]  

  • 46. Unequal allocation and allocation concealment.
    Palys KE; Berger VW; Grant WC
    Stat Med; 2012 Dec; 31(29):4135-6; author reply 4137. PubMed ID: 23175158
    [No Abstract]   [Full Text] [Related]  

  • 47. The random allocation of patients in clinical trials.
    Deeley J
    Methods Inf Med; 1966 Apr; 5(2):100-1. PubMed ID: 21203659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Probability screening in manuscripts submitted to biomedical journals--an effective tool or a statistical quagmire?
    Miller DR
    Anaesthesia; 2015 Jul; 70(7):765-8. PubMed ID: 26033111
    [No Abstract]   [Full Text] [Related]  

  • 49. Sequence Generation and Allocation Concealment.
    Berger VW
    J Evid Based Dent Pract; 2016 Jun; 16(2):145-6. PubMed ID: 27449850
    [No Abstract]   [Full Text] [Related]  

  • 50. Reply to Sequence Generation and Allocation Concealment.
    Faggion CM
    J Evid Based Dent Pract; 2016 Jun; 16(2):146. PubMed ID: 27449851
    [No Abstract]   [Full Text] [Related]  

  • 51. Measuring the detriment of treatment: number needed to harm.
    Sedgwick P
    BMJ; 2015 May; 350():h2763. PubMed ID: 26002193
    [No Abstract]   [Full Text] [Related]  

  • 52. The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC): the first platform facilitating 'trials within cohorts' (TwiCs) for the evaluation of interventions for prostate cancer.
    Teunissen FR; Willigenburg T; Meijer RP; van Melick HHE; Verkooijen HM; van der Voort van Zyp JRN
    World J Urol; 2022 Sep; 40(9):2205-2212. PubMed ID: 35861861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Utrecht cohort for Multiple BREast cancer intervention studies and Long-term evaLuAtion (UMBRELLA): objectives, design, and baseline results.
    Young-Afat DA; van Gils CH; van den Bongard HJGD; Verkooijen HM;
    Breast Cancer Res Treat; 2017 Jul; 164(2):445-450. PubMed ID: 28444532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary care randomised controlled trial of a tailored interactive website for the self-management of respiratory infections (Internet Doctor).
    Little P; Stuart B; Andreou P; McDermott L; Joseph J; Mullee M; Moore M; Broomfield S; Thomas T; Yardley L
    BMJ Open; 2016 Apr; 6(4):e009769. PubMed ID: 27098821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Palliative care for the management of chronic illness: a systematic review study protocol.
    Effiong A; Effiong AI
    BMJ Open; 2012; 2(3):. PubMed ID: 22614173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Controlled trials: allocation concealment, random allocation, and blinding.
    Sedgwick P
    BMJ; 2015 May; 350():h2633. PubMed ID: 25979365
    [No Abstract]   [Full Text] [Related]  

  • 57. Randomization, permuted blocks, masking, allocation concealment, and selection bias in the Tobacco Quit Line Study.
    Berger VW
    Contemp Clin Trials; 2010 May; 31(3):201. PubMed ID: 20219696
    [No Abstract]   [Full Text] [Related]  

  • 58. Assessing allocation concealment and blinding in randomized controlled trials: why bother?
    Schulz KF
    ACP J Club; 2000; 132(2):A11-2. PubMed ID: 10750446
    [No Abstract]   [Full Text] [Related]  

  • 59. Nicotine-replacement therapy in pregnancy-the end of the road?
    Koren G
    Ther Drug Monit; 2012 Oct; 34(5):487-8. PubMed ID: 22960737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta-analysis.
    Myung SK; Ju W; Jung HS; Park CH; Oh SW; Seo H; Kim H;
    BJOG; 2012 Aug; 119(9):1029-39. PubMed ID: 22780818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.